Independence of Peripheral Brain-Derived Neurotrophic Factor from Depression and Anxiety Symptoms in Cocaine Use Disorder: An Initial Description
Authors:
- Dannia M. Islas-PreciadoDIDannia M. Islas-Preciado
- Ruth Alcalá-LozanoRARuth Alcalá-Lozano
- Erika P. Aguilar-VelazquezErika P. Aguilar-Velazquez
- Yvonne G. Flores-MedinaYFYvonne G. Flores-Medina
- Nelly M. Vega-RiveraNVNelly M. Vega-Rivera
- Erika Estrada-CamarenaErika Estrada-Camarena
- Ruben Carino-EscobarRCRuben Carino-Escobar
- Jorge J. González-OlveraJGJorge J. González-Olvera
- Erik D. Morelos-SantanaEMErik D. Morelos-Santana
Open Access
- 27 August 2025
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 26 (17) , 8294
Abstract
Cocaine use disorder (CUD) presents high comorbidity with mood symptoms that impair recovery processes and facilitate relapses. Peripheral brain-derived neurotrophic factor (BDNF) is negatively correlated with mood symptoms in depressive disorders. However, whether a correlation exists between BDNF and mood in CUD is still unknown. Thus, in this cross-sectional study, we explored the potential relationship between peripheral BDNF levels and depression and anxiety symptoms in CUD. Serum peripheral BDNF was determined by the ELISA method. Standardized Hamilton Depression (HDRS) and Anxiety (HARS) inventories were administered. Twenty-nine seeking-treatment CUD participants under stable medication (female = 3) were enrolled. According to the mood severity, 34.48% of participants were classified as normal, 24.14% as moderate, and 41.38% as severe symptoms (p < 0.001). Peripheral BDNF was similar between the different mood severity groups (p > 0.05). No correlation between BDNF and HDRS and BDNF and HARS was detected regardless of the severity of mood symptoms (p > 0.05). Different from what has been observed in depressive disorders, independence between peripheral BDNF levels and mood symptoms in CUD was observed. This finding suggests a singular, intricate regulation of peripheral BDNF and mood as part of CUD-related maladaptations that might disrupt the expected antidepressant response and perpetuate mood symptoms in CUD.Keywords
Funding Information
- Punto de Partida A.C.
This publication has 65 references indexed in Scilit:
- Association of peripheral manifestation of brain‐derived neurotrophic factor with depression: A meta‐analysisBrain and Behavior, 2022
- BDNF as a therapeutic candidate for cocaine use disordersAddiction Neuroscience, 2022
- Brain-Derived Neurotrophic Factor Signaling in Depression and Antidepressant ActionBiological Psychiatry, 2021
- Trends and correlates of cocaine use and cocaine use disorder in the United States from 2011 to 2015Drug and Alcohol Dependence, 2017
- BDNF: A Key Factor with Multipotent Impact on Brain Signaling and Synaptic PlasticityCellular and Molecular Neurobiology, 2017
- Antidepressants for cocaine dependence and problematic cocaine useCochrane Database of Systematic Reviews, 2011
- Increased Serum Brain-Derived Neurotrophic Factor Is Predictive of Cocaine Relapse Outcomes: A Prospective StudyBiological Psychiatry, 2011
- Tropomyosin-Related Kinase B in the Mesolimbic Dopamine System: Region-Specific Effects on Cocaine RewardBiological Psychiatry, 2009
- Alterations in BDNF and trkB mRNAs following acute or sensitizing cocaine treatments and withdrawalBrain Research, 2006
- Altered Gene Expression of Brain-Derived Neurotrophic Factor and Receptor Tyrosine Kinase B in Postmortem Brain of Suicide SubjectsArchives of General Psychiatry, 2003